Evidence map›Paper›PMID 33135460›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2021

Assessment of individual and standardized glucagon kinetics in healthy humans.

Marcello C Laurenti, Adrian Vella, Jon D Adams, Daniel J Schembri Wismayer, Aoife M Egan, Chiara Dalla Man

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance.The Journal of clinical endocrinology and metabolism · 2025
    Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects.IEEE transactions on bio-medical engineering · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marcello C LaurentiDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.
Adrian VellaDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.ORCID 0000-0001-6493-7837
Jon D AdamsDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.
Daniel J Schembri WismayerDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.
Aoife M EganDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota.
Chiara Dalla ManDepartment of Information Engineering, University of Padova, Padova, Italy.ORCID 0000-0002-4908-0596
Mayo Clinic · USUniversity of Padua · IT

Funding

The regulation of fasting glucose metabolism in people with and without prediabetesR01DK078646 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2007 to 2026
$8.7M
Glucagon suppression and diabetes-associated variation in TCF7L2R01DK116231 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2017 to 2026
$5.4M
The effect of endogenous GLP-1 secretion on islet function in vivoR01DK126206 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2020 to 2026
$4.0M
HHS | National Institutes of Health (NIH) DK116231HHS | National Institutes of Health (NIH) DK126206HHS | National Institutes of Health (NIH) DK78646NIDDK NIH HHS R01 DK078646NIDDK NIH HHS R01 DK116231NIDDK NIH HHS R01 DK126206
6 · The paper itself

Abstract

Impaired glucose tolerance arises out of impaired postprandial insulin secretion and delayed suppression of glucagon. These defects occur early and independently in the pathogenesis of prediabetes. Quantification of the contribution of α-cell dysfunction to glucose tolerance has been lacking because knowledge of glucagon kinetics in humans is limited. Therefore, in a series of experiments examining the interaction of glucagon suppression with insulin secretion we studied 51 nondiabetic subjects (age = 54 ± 13 yr, BMI = 28 ± 4 kg/m

Indexed as

AdultAgedAlgorithmsAnthropometryBody Mass IndexC-PeptideFemaleGlucagonGlucoseHealthy VolunteersHumansInsulin SecretionKineticsMaleMiddle AgedReference ValuesC-PeptideGlucagonGlucoseSomatostatinclearanceglucagonimpaired glucose toleranceprediabetesα-cell

Identifiers

PMID33135460
PMCPMC8194411
OpenAlexW3097018393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.